Skip to content

Kcnq1 Related Disorder Cn239322

Published: July 22, 2026Updated: August 20, 2026

A genetic condition affecting potassium channels, often causing heart rhythm abnormalities and sometimes hearing loss. Management includes cardiac monitoring and symptom-specific treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Syncope

!

QT Prolongation

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Palpitations

(cardiovascular)

Dizziness

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Beta-blocker therapy

Chronic beta-blocker therapy to reduce cardiac events and sudden death risk in congenital KCNQ1-related disorders. Typically maintained lifelong.

medication
2

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Regular cardiac evaluation and genetic testing

Comprehensive cardiac assessment including ECG, echocardiogram, and exercise stress testing. Cascade genetic testing for family members is recommended.

monitoring

Additional treatment options

ICD implantation

Defibrillator implantation for primary or secondary prevention of sudden cardiac death in high-risk patients with confirmed KCNQ1 mutations.

surgical

Left cardiac sympathetic denervation

Surgical intervention to reduce sympathetic innervation to the heart for patients with recurrent events despite beta-blocker therapy.

procedure

Activity modification and trigger avoidance

Avoidance of competitive sports, swimming alone, and other known triggers. Development of individualized exercise guidelines based on risk stratification.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Kcnq1 Related Disorder Cn239322?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Kcnq1 Related Disorder Cn239322. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy